Showing results (1051-1060 of 3,716) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|November 11, 1999
Phase I study of liposomal daunorubicin in patients with acute leukemiaJ Cortes, S O'Brien, E Estey, et al.Investigational New Drugs|November 18, 2000
Capecitabine: preclinical pharmacology studiesH IshitsukaInvestigational New Drugs|November 18, 2000
Preclinical development of eniluracil: enhancing the therapeutic index and dosing convenience of 5-fluorouracilM T Paff, D P Baccanari, S T Davis, et al.Investigational New Drugs|November 18, 2000
Clinical development of eniluracil/fluorouracil: an oral treatment for patients with solid tumorsJ Levin, J HohnekerInvestigational New Drugs|January 13, 2023
Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational StudyEmi Ishikawa, Yuta Yokoyama, Haruna Chishima, et al.Investigational New Drugs|January 1, 1983
Effects of harringtonine in combination with acivicin, adriamycin, L-asparaginase, cytosine arabinoside, dexamethasone, fluorouracil or methotrexate on human acute myelogenous leukemia cell line KG-1T Okano, T Ohnuma, J F Holland, et al.Investigational New Drugs|May 1, 1993
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)S Danhauser-Riedl, E Hausmann, H D Schick, et al.Investigational New Drugs|January 1, 1995
Adenocarcinoma of unknown primary: retrospective analysis of chemosensitivity of 313 freshly explanted tumors in a tumor cloning systemA R Hanauske, G M Clark, D D Von HoffInvestigational New Drugs|January 1, 1995
Phase I trial of pentosan polysulfateS M Swain, B Parker, A Wellstein, et al.Investigational New Drugs|January 1, 1995
Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: a Southwest Oncology Group studyS K Williamson, J J Crowley, R B Livingston, et al.Pageof 372